Diarrhea Clinical Trial
Official title:
A Nutritional Trial on Effect of Probiotic Yoghurt Containing Lactobacillus Rhamnosus Yoba 2012 on Respiratory Tract Infection and Other Health Outcomes Among Children Aged 3-6 Years in Southwest Uganda
This is a nutritional observational trial with two arms: 1) Intervention arm of Probiotic Yoghurt containing Lactobacillus rhamnosus yoba 2012 and 2) Control arm of milk. About 500 children in each arm will be enrolled. Children will be enrolled in the yoghurt or the milk arm, based on the preference of the school and the parents in response to a sensitization campaign of a non-governmental organization (NGO) in the region. This selection will therefore be non-randomized and non-blinded. Within one school, all children will be enrolled in the same arm. The children will be monitored for 3 weeks in the baseline. Subsequently, the children will consume either 100ml of yoghurt or 100ml of milk, once per day for five days per week for nine weeks, while being continuously monitored. The milk and the yoghurt will be locally sourced in the district where the schools are located.
This is an observational nutritional trial with two arms: 1) Intervention arm of Probiotic
Yoghurt containing Lactobacillus rhamnosus yoba 2012 and 2) Control arm of milk. About 500
children in each arm will be enrolled. Children will be enrolled in the yoghurt or the milk
arm, based on the preference of the school and the parents in response to a sensitization
campaign of an NGO in the region. This selection will therefore be non-randomized and
non-blinded. Within one school, all children will be enrolled in the same arm. The children
will be monitored for 3 weeks in the baseline. Subsequently, the children will consume either
100ml of yoghurt or 100ml of milk, once per day for five days per week for nine weeks, while
being continuously monitored. The milk and the yoghurt will be locally sourced in the
district where the schools are located. Monitoring and data collection tools include:
1. Baseline, midline and end line questionnaire administered to parents to identify
confounding factors (e.g. use of medication and diet from home) of treatment and control
group.
2. Weight, height, mid-upper-arm circumference MUAC and head circumference measurements
every 4 weeks for 3 months in both the treatment and control groups (total 4 times). One
point measurement will be taken 6 months after the study.
3. Daily monitoring of the incidence of RTIs, diarrhoea, skin rashes or other diseases in
treatment and control groups by teachers with confirmation of a nurse in a mobile app.
Children from pre-primary institutions in which both the management and the parents have
recently decided to purchase either milk or yoghurt for the pupils on regular basis will be
recruited. The study subjects (children) are recruited at these institutions. Only children
from parents who have agreed to contribute to the consumption of milk / yoghurt and who have
furthermore consented for their children to be measured and monitored for the purpose of the
current study will be recruited. The parent is free to provide his/her child with milk /
yoghurt, even if the parent does not consent for the child to take part in the study.
The study will start three weeks before either milk or yoghurt consumption commences, in
order to establish a solid baseline. With the help of tablets and a specially designed app,
nurses will keep track of their pupils' health by tracking incidence of diarrhoea,
respiratory tract infections, skin rashes and other diseases. Teachers will keep track of the
daily attendance of pupils.
Measurements of weight, height, MUAC and head circumference will be measured by a nurse every
four weeks, starting three weeks prior to the start of the consumption of either milk or
yoghurt. The measurements will be conducted with the help of Standard Operations Procedures
as provided by Life Study and analysed with the help of World Health Organization (WHO)
guidelines.
During these 3 months in which the children will be monitored, a questionnaire will be
administered to the parents of the children at the start, middle and end of the study. The
primary objective and content of the questionnaire is related to diet of the children outside
school, in order to determine whether there are significant differences between the diets of
the children in the treatment group and in the control group. The questionnaires will
furthermore include questions about absenteeism and causes thereof, incidence of diarrhoea,
Respiratory Tract Infections or any other diseases, and the use of any type of drug or
treatment, in order to verify and supplement the information provided by the class-teacher.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06283784 -
Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients
|
N/A | |
Recruiting |
NCT03851835 -
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
|
Phase 3 | |
Completed |
NCT04003181 -
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
|
N/A | |
Completed |
NCT03596827 -
The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection
|
N/A | |
Recruiting |
NCT05372068 -
Cement flooRs AnD chiLd hEalth (CRADLE)
|
N/A | |
Completed |
NCT03972618 -
Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic
|
N/A | |
Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
Not yet recruiting |
NCT05052489 -
Registry and Clinical Observation of Children With Diarrhoeal Disease
|
||
Completed |
NCT02541695 -
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
|
N/A | |
Completed |
NCT02428647 -
Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT01968408 -
Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children
|
Phase 3 | |
Completed |
NCT01739231 -
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
|
Phase 1/Phase 2 | |
Completed |
NCT01371656 -
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
|
Phase 3 | |
Not yet recruiting |
NCT01382199 -
Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
|
Phase 3 | |
Terminated |
NCT01048567 -
Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly
|
Phase 2 | |
Terminated |
NCT01472211 -
Water-based Zinc Intervention Trial in Zinc Deficient Children
|
Phase 0 | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Completed |
NCT00914225 -
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
N/A | |
Completed |
NCT00760851 -
Yogurt Study in Children 2-4 Years Old Attending Daycare
|
Phase 3 |